Transient Ischemic Attack (ICD-11: 8B10) - Complete Coding Guide

1. Introduction

Transient ischemic attack (TIA), known internationally as TIA (Transient Ischemic Attack), represents a neurological emergency that functions as an important warning sign for more severe cerebrovascular events. It is a transient episode of focal neurological dysfunction caused by cerebral or retinal ischemia, characterized by complete resolution of symptoms within 24 hours, without evidence of acute infarction in clinically relevant areas of the brain.

The clinical importance of TIA cannot be underestimated. This event functions as a harbinger of complete stroke (CVA), offering a crucial window of opportunity for preventive intervention. Studies demonstrate that patients who suffer a TIA present significantly elevated risk of developing a complete ischemic stroke in subsequent weeks, especially in the first 48 to 72 hours after the initial event.

From an epidemiological standpoint, TIA represents a considerable challenge for healthcare systems worldwide. Incidence increases progressively with age, being more common in populations over 65 years old. Furthermore, the presence of cardiovascular risk factors such as arterial hypertension, diabetes mellitus, dyslipidemia, atrial fibrillation, and smoking substantially elevates the probability of occurrence of these events.

Correct coding of TIA is absolutely critical for multiple reasons. First, it enables appropriate epidemiological tracking of this condition, facilitating the allocation of public health resources and the development of preventive policies. Second, it ensures precise communication among healthcare professionals, essential for continuity of care. Third, it assures appropriate reimbursement for services rendered and justifies the need for in-depth diagnostic investigation and aggressive preventive treatment. The clear distinction between TIA and complete ischemic stroke has significant implications in clinical management, prognosis, and patient risk stratification.

2. Correct ICD-11 Code

Code: 8B10

Description: Transient ischemic attack

Parent category: null - Cerebral ischemia

Official definition: Transient episode of focal neurological dysfunction caused by focal cerebral ischemia without acute infarction in the clinically relevant area of the brain or transient monocular vision loss due to retinal ischemia. Symptoms must completely disappear within 24 hours.

Code 8B10 is inserted in the chapter on nervous system diseases of ICD-11, specifically in the section on cerebrovascular diseases. This classification reflects the transient and reversible nature of the event, clearly differentiating it from permanent ischemic lesions that result in established cerebral infarction.

The definition emphasizes three crucial elements: first, the transient nature of neurological dysfunction; second, the absence of demonstrable acute infarction on neuroimaging examinations in clinically relevant areas; third, the 24-hour time limit for complete symptom resolution. This latter criterion represents an important conceptual change, as older definitions were based exclusively on time, while the modern definition also incorporates neuroimaging findings, recognizing that many TIAs actually resolve in less than one hour.

The specific inclusion of transient monocular vision loss (amaurosis fugax) in the definition recognizes that retinal ischemia represents a manifestation of the same pathophysiological process that affects the brain, deserving the same attention and urgency in clinical management.

3. When to Use This Code

Code 8B10 should be used in specific clinical situations where diagnostic criteria are clearly present. Below, we present detailed practical scenarios:

Scenario 1: Resolved transient hemiparesis A 68-year-old patient presents to the emergency department reporting an episode of sudden weakness in the right arm and leg occurring three hours prior, lasting approximately 45 minutes, followed by complete recovery. Neurological examination upon arrival is completely normal. Computed tomography of the skull demonstrates no acute lesions, and magnetic resonance imaging with diffusion also shows no areas of acute infarction. This is a classic case for using code 8B10.

Scenario 2: Transient aphasia A 72-year-old patient with a history of atrial fibrillation suddenly develops difficulty speaking and understanding verbal commands. Family members bring the patient to the hospital 30 minutes after symptom onset. During initial evaluation, the aphasia is already markedly improving, and two hours after onset, the patient is completely asymptomatic. Neuroimaging shows no acute infarction. Code 8B10 is appropriate.

Scenario 3: Amaurosis fugax A 65-year-old patient reports an episode of sudden monocular vision loss in the left eye, described as "a curtain coming down," lasting five minutes, followed by complete visual recovery. Ophthalmological examination is normal, as is neuroimaging. Vascular investigation reveals significant ipsilateral carotid stenosis. This presentation of transient retinal ischemia justifies the use of code 8B10.

Scenario 4: Isolated transient sensory deficit A patient presents with sudden paresthesia and numbness in the entire right hemiface and right upper limb, lasting 20 minutes, with complete resolution. Neurological examination normal on evaluation. Magnetic resonance imaging without evidence of acute lesion. Code 8B10 is appropriate.

Scenario 5: Transient dysarthria and ataxia A patient develops slurred speech and sudden imbalance, suggestive of ischemia in the vertebrobasilar territory. Symptoms last 15 minutes and completely resolve before hospital arrival. Neuroimaging without acute lesions. Code 8B10 should be used.

Scenario 6: Multiple transient neurological deficits A patient presents with a combination of right facial weakness, speech difficulty, and numbness in the right upper limb, with total duration of 90 minutes. All symptoms completely resolve, and magnetic resonance imaging shows no infarction. Despite the multiplicity of symptoms, the transient nature and absence of infarction justify code 8B10.

In all these scenarios, the essential criteria are present: focal neurological symptoms of sudden onset, presumed ischemic mechanism, complete resolution in less than 24 hours, and absence of acute infarction on neuroimaging.

4. When NOT to Use This Code

It is fundamental to recognize situations where code 8B10 is not appropriate, avoiding coding errors that may compromise the quality of medical records and epidemiological analysis.

Exclusion 1: Neonatal cerebral ischemia If the patient is a newborn presenting signs of cerebral ischemia, even if transient, the appropriate code is 1526436336 (Neonatal cerebral ischemia). The neonatal period has distinct pathophysiological characteristics that justify separate coding.

Exclusion 2: Transient global amnesia Patients presenting with an episode of isolated anterograde memory loss, without other focal neurological deficits, characterize transient global amnesia and should receive code 1524600518. Although transient, this condition does not represent typical focal cerebral ischemia and has a distinct pathophysiological mechanism.

Exclusion 3: Established ischemic stroke If neuroimaging demonstrates acute infarction in the area corresponding to clinical symptoms, even if symptoms have improved or resolved, the correct code is 8B11 (Ischemic cerebral accident), not 8B10. The presence of established infarction fundamentally changes the diagnosis.

Exclusion 4: Symptoms persisting beyond 24 hours If neurological symptoms persist for more than 24 hours, regardless of the presence or absence of infarction on neuroimaging, the diagnosis is no longer TIA. One should consider 8B11 or other neurological conditions.

Exclusion 5: Non-focal symptoms Symptoms such as isolated syncope, global mental confusion, isolated dizziness without other focal neurological signs, or isolated headache do not characterize TIA and should not be coded as 8B10. TIA requires focal neurological deficit.

Exclusion 6: Non-ischemic causes Transient neurological symptoms secondary to migraine with aura, seizures, hypoglycemia, or other metabolic causes should not be coded as 8B10, even if they clinically mimic TIA. Investigation should establish ischemic etiology.

5. Step-by-Step Coding Process

Step 1: Assess diagnostic criteria

Confirmation of TIA diagnosis requires careful clinical evaluation and appropriate complementary investigation. Begin with detailed clinical history, focusing on sudden onset of symptoms, focal nature of neurological deficit, symptom duration, and presence of vascular risk factors.

Neurological examination should be performed as early as possible, ideally during the symptomatic event, although patients frequently arrive after symptom resolution. Carefully document any residual deficit or abnormal neurological signs.

Neuroimaging is essential. Non-contrast computed tomography of the skull is generally the first examination, mainly to exclude hemorrhage. Magnetic resonance imaging with diffusion sequences is more sensitive for detecting small acute infarcts and should preferably be performed within the first 24 to 48 hours.

Complementary vascular investigation includes ultrasound with Doppler of carotid and vertebral arteries, angiography computed tomography or magnetic resonance angiography, depending on availability and clinical suspicion. Cardiac evaluation with electrocardiogram and echocardiogram may be necessary to identify cardioembolic sources.

Step 2: Verify specifiers

Although code 8B10 does not have multiple formal specifiers in ICD-11, it is important to document relevant clinical characteristics that may influence management and prognosis.

Document the exact duration of symptoms when possible. Most true TIAs resolve in less than one hour, and longer durations may indicate higher risk of recurrence.

Identify the affected vascular territory (anterior versus posterior circulation, specific middle, anterior, or posterior cerebral artery territory). This information guides subsequent etiological investigation.

Record the presumed mechanism: atherothrombotic (large artery stenosis), cardioembolic, small vessel disease, or cryptogenic. This etiological classification, although not part of the code, is crucial for preventive treatment.

Calculate risk scores such as ABCD2 or ABCD3-I, which stratify the risk of subsequent stroke and aid in decisions regarding hospital admission versus outpatient management.

Step 3: Differentiate from other codes

The most critical differentiation is between 8B10 (Transient ischemic attack) and 8B11 (Ischemic cerebral accident). The key lies in the presence or absence of acute infarction on neuroimaging in clinically relevant areas.

If diffusion-weighted magnetic resonance imaging demonstrates an area of diffusion restriction corresponding to clinical symptoms, the diagnosis is ischemic stroke (8B11), even if symptoms have completely resolved. The presence of permanent tissue lesion defines stroke, not symptom duration.

Conversely, if symptoms persist beyond 24 hours but there is no demonstrable infarction on high-quality neuroimaging, the situation is more complex. Historically, this would be called "reversible ischemic neurological deficit" (RIND), but in modern practice, it is generally coded as 8B11 due to persistent symptoms.

Also differentiate from conditions that mimic TIA: hemiplegic migraine, focal seizures with Todd's paralysis, hypoglycemia, syncope, peripheral vertigo, and psychogenic disorders. Detailed clinical history and appropriate investigation are essential.

Step 4: Required documentation

Adequate documentation is fundamental to justify coding and ensure continuity of care. Your record should include:

Mandatory documentation checklist:

• Detailed description of focal neurological symptoms presented
• Exact time of symptom onset and resolution
• Total duration of symptomatic episode
• Neurological examination at time of evaluation (even if normal)
• Neuroimaging results with date and type of examination performed
• Specific absence of acute infarction in clinically relevant areas
• Cardiovascular risk factors present
• Medications in use, especially anticoagulants and antiplatelet agents
• Vascular investigation performed or scheduled
• Risk score calculated (ABCD2 or similar)
• Preventive treatment plan instituted

This documentation not only justifies code 8B10, but also provides crucial information for subsequent patient management and risk stratification.

6. Complete Practical Example

Clinical Case

A 70-year-old male patient presents to the emergency department at 2:30 PM accompanied by his wife. She reports that at 1:00 PM, while they were having lunch, the patient suddenly dropped his fork from his right hand and began to have difficulty speaking. When he attempted to stand up, he demonstrated weakness in his right leg and almost fell.

His wife immediately called emergency services. During transport, which lasted approximately 20 minutes, she noticed progressive improvement. Upon arrival at the hospital, the patient was already able to move his right arm, although with mild weakness, and his speech was practically normal.

Past medical history reveals arterial hypertension for 15 years, on irregular use of amlodipine and hydrochlorothiazide. Dyslipidemia diagnosed 5 years ago, currently untreated. Former smoker (quit 10 years ago, smoking history of 30 pack-years). Denies diabetes, known cardiac disease, or previous vascular events.

On initial physical examination at 2:45 PM (1 hour and 45 minutes after symptom onset), patient alert, oriented, cooperative. Blood pressure 168/95 mmHg, heart rate 78 bpm regular. Neurological examination: fluent speech and preserved comprehension, mild residual dysarthria. Muscle strength grade 4+/5 in right upper extremity and grade 5-/5 in right lower extremity. Reflexes symmetric, Babinski sign absent bilaterally. Sensation preserved. Coordination and gait not tested due to residual motor deficit.

At 3:30 PM, neurological reassessment demonstrates complete resolution of all deficits. Muscle strength grade 5/5 in all segments, dysarthria completely resolved, normal gait.

Non-contrast computed tomography of the skull performed at 3:00 PM demonstrates no hemorrhage, acute ischemic lesions, or other significant abnormalities besides mild leukoaraiosis. Brain magnetic resonance imaging with diffusion performed at 6:00 PM reveals no areas of restricted diffusion or other acute lesions.

Electrocardiogram: sinus rhythm, without ischemic changes. Doppler ultrasound of carotids: calcified atherosclerotic plaque at left carotid bifurcation causing stenosis of approximately 60%, right carotid with non-obstructive plaques. Transthoracic echocardiogram: preserved ventricular function, without thrombi or significant structural abnormalities.

Laboratory tests: fasting glucose 108 mg/dL, glycated hemoglobin 5.8%, total cholesterol 245 mg/dL, LDL 165 mg/dL, HDL 38 mg/dL, triglycerides 210 mg/dL, creatinine 1.1 mg/dL, normal complete blood count, normal coagulation studies.

Step-by-Step Coding

Criteria analysis:

1. Focal neurological dysfunction: Present - right hemiparesis and dysarthria of sudden onset
2. Transient nature: Confirmed - complete resolution in approximately 2 hours and 30 minutes
3. Duration less than 24 hours: Yes - symptoms lasted less than 3 hours
4. Absence of acute infarction on neuroimaging: Confirmed - CT and MRI with diffusion negative for acute lesions
5. Ischemic mechanism: Probable - ipsilateral carotid stenosis to symptoms (left hemisphere controlling right side of body)

Code selected: 8B10 - Transient ischemic attack

Complete justification:

This case meets all diagnostic criteria for TIA as defined by ICD-11. The patient presented with an episode of focal neurological dysfunction (right hemiparesis and dysarthria) of sudden onset, compatible with ischemia in the territory of the left middle cerebral artery. Complete resolution of symptoms in less than 3 hours meets the criterion of transience.

Crucially, both computed tomography and magnetic resonance imaging with diffusion sequences, performed within the appropriate window, demonstrated no acute infarction in the clinically relevant areas. This finding is essential to differentiate TIA (8B10) from ischemic stroke (8B11).

Vascular investigation revealed significant left carotid stenosis, providing a plausible mechanism for the transient ischemic event and identifying a target for secondary preventive intervention.

Applicable complementary codes:

• [BA00.0](/en/code/BA00.0) - Essential arterial hypertension (risk factor present)
• 5C80 - Mixed dyslipidemia (risk factor present)
• Codes for neuroimaging procedures performed
• Codes for preventive treatment instituted (platelet aggregation inhibitor, statin)

7. Related Codes and Differentiation

Within the Same Category

8B11: Ischemic stroke

The differentiation between 8B10 and 8B11 is the most critical in clinical practice of cerebrovascular diseases. The fundamental distinction is based on two main criteria:

When to use 8B10 (TIA): Transient focal neurological symptoms that completely resolve within 24 hours AND absence of demonstrable acute infarction on neuroimaging in clinically relevant areas.

When to use 8B11 (Ischemic stroke): Presence of acute cerebral infarction demonstrated on neuroimaging (especially diffusion-weighted MRI) in areas corresponding to clinical symptoms, OR persistence of focal neurological symptoms beyond 24 hours.

Main difference: The presence of permanent tissue injury (infarction) defines stroke, regardless of symptom duration or resolution. Patients may have symptoms that completely resolve but still have ischemic stroke if neuroimaging demonstrates infarction. Conversely, symptoms lasting only minutes but without infarction on neuroimaging characterize TIA.

This distinction has significant implications: ischemic stroke generally requires longer hospitalization, more extensive investigation, and may have different prognosis in terms of recurrence risk and long-term sequelae.

Differential Diagnoses

Migraine with aura: Can cause transient focal neurological symptoms, but typically with gradual onset (over 5-20 minutes), positive symptoms (paresthesias, scintillating visual phenomena) rather than negative (weakness, visual loss), and often followed by headache. Previous history of migraine aids in diagnosis.

Focal seizures: Can cause focal motor or sensory symptoms, but generally with positive characteristics (clonic movements, paresthesias), different temporal progression (Jacksonian march), and possible post-ictal Todd's paralysis. Electroencephalogram may assist.

Hypoglycemia: Can cause varied neurological symptoms, but generally bilateral or global, associated with autonomic symptoms (diaphoresis, tremors, palpitations), and low capillary glucose at symptom onset.

Syncope: Causes transient loss of consciousness, but not focal neurological deficits. Recovery is rapid and complete upon resuming horizontal position.

8. Differences with ICD-10

In ICD-10, transient ischemic attack was coded as G45 (Transient cerebral ischemic accidents and related syndromes), with subdivisions including:

• G45.0 - Vertebrobasilar syndrome
• G45.1 - Carotid artery syndrome (hemispheric)
• G45.2 - Syndromes of multiple and bilateral pre-cerebral arteries
• G45.3 - Amaurosis fugax
• G45.9 - Unspecified transient cerebral ischemic accident

The main change in ICD-11 is the simplification to a single code (8B10) without mandatory subdivisions by vascular territory. This change reflects the modern understanding that the most important distinction is between TIA and established stroke, not between different affected vascular territories.

Another significant change is the explicit incorporation of neuroimaging criteria in the definition. ICD-10 was based primarily on the temporal criterion of 24 hours, whereas ICD-11 emphasizes the absence of acute infarction on neuroimaging, recognizing that this is the true differentiator between TIA and stroke.

The specific inclusion of amaurosis fugax (transient monocular vision loss) in the main definition of 8B10, rather than a separate code, reflects the recognition that it represents the same pathophysiological entity affecting retinal territory.

Practical impact: The transition to ICD-11 simplifies coding, eliminating the need to specify vascular territory in the main code. However, clinical documentation should still include this information. The emphasis on neuroimaging may require broader access to magnetic resonance imaging for accurate coding, potentially challenging in healthcare systems with limited resources.

9. Frequently Asked Questions

1. How is transient ischemic attack diagnosed?

The diagnosis of TIA is fundamentally clinical, based on the history of focal neurological symptoms of sudden onset with complete resolution. However, confirmation requires complementary investigation. Neuroimaging, especially magnetic resonance imaging with diffusion sequences, is essential to exclude acute infarction and confirm the transient nature without permanent lesion. Vascular investigation (carotid doppler, angiography computed tomography, or magnetic resonance angiography) identifies the source of ischemia. Cardiac evaluation (electrocardiogram, echocardiogram, rhythm monitoring) seeks cardioembolic sources. Laboratory tests evaluate risk factors and less common causes. Definitive diagnosis requires exclusion of other causes of transient neurological symptoms.

2. Is treatment available in public health systems?

TIA treatment consists mainly of secondary stroke prevention and is widely available in public health systems in most countries. Essential medications include antiplatelet agents (acetylsalicylic acid, clopidogrel) and statins, which are relatively accessible and available in basic formularies. For patients with atrial fibrillation, oral anticoagulants are necessary. Control of risk factors (hypertension, diabetes, dyslipidemia) uses commonly available medications. Basic diagnostic investigation (computed tomography, doppler) is generally accessible, although magnetic resonance imaging may have more limited availability in some systems. Procedures such as carotid endarterectomy or angioplasty may have variable availability depending on the health system.

3. How long does treatment last?

Preventive treatment after TIA is generally prolonged or permanent. Antiplatelet agents are typically maintained indefinitely to prevent recurrent vascular events. Statins are also generally continued long-term, regardless of cholesterol levels, due to pleiotropic benefit in stabilizing atherosclerotic plaques. Anticoagulants for patients with atrial fibrillation are maintained indefinitely, except for contraindications. Medications for blood pressure and diabetes control are adjusted as needed but generally require continuous use. Medical follow-up is more frequent in the first months (maximum stroke risk), with visits initially monthly, then quarterly, and eventually semiannually or annually for long-term monitoring.

4. Can this code be used in medical certificates?

Yes, code 8B10 can and should be used in medical certificates when appropriate. TIA is a neurological emergency that justifies absence from work or usual activities for urgent investigation and initiation of preventive treatment. The period of absence varies according to individual clinical situation, complexity of necessary investigation, and risk of recurrence. Typically, initial absence of 7 to 15 days is reasonable to complete basic investigation and clinical stabilization. Patients in high-risk occupations (heavy machinery operators, pilots, professional drivers) may require longer absence and specialist evaluation before return. Documentation should specify "transient ischemic attack" or use the ICD-11 code 8B10, providing adequate justification for the absence.

5. What is the difference between TIA and "mini-stroke"?

The term "mini-stroke" is an imprecise popular denomination that can cause confusion. Frequently, lay people use this term to refer to TIA, but this nomenclature is inadequate because it suggests that the event is less serious or requires less attention. In reality, TIA is a medical emergency that requires urgent evaluation and treatment. Some use "mini-stroke" to describe small ischemic strokes with mild symptoms, which would be coded as 8B11, not 8B10. The correct distinction is: TIA (8B10) has symptoms that resolve completely without infarction on neuroimaging; ischemic stroke (8B11) has demonstrable infarction or persistent symptoms. Both require urgent and aggressive treatment.

6. Can I have another TIA or stroke after the first episode?

Yes, the risk of recurrence is significant, especially in the first weeks after a TIA. Studies demonstrate that approximately 10-20% of patients who suffer a TIA develop complete stroke within the first 90 days, with greater risk in the first 48-72 hours. This elevated risk justifies the urgency in investigation and initiation of preventive treatment. Factors that increase the risk of recurrence include advanced age, diabetes, hypertension, significant carotid stenosis, atrial fibrillation, and multiple TIA episodes. Adequate preventive treatment (antiplatelet or anticoagulant agents, statins, risk factor control) substantially reduces this risk, but does not eliminate it completely. Regular medical follow-up and treatment adherence are essential.

7. Do I need to be hospitalized after a TIA?

The need for hospital admission depends on individual risk stratification. High-risk patients (ABCD2 scores ≥4, severe carotid stenosis, unanticoagulated atrial fibrillation, multiple recent episodes, worsening or fluctuating symptoms) generally require admission for urgent investigation and monitoring. Lower-risk patients can be managed on an outpatient basis if there is assurance of complete investigation and follow-up within 24-48 hours. The availability of specialized cerebrovascular emergency services (TIA clinics) allows safe outpatient management of selected cases. The decision should be individualized considering not only clinical risk, but also social factors, treatment adherence capacity, and access to follow-up services.

8. What are the warning signs I should recognize?

The warning signs of TIA or stroke follow the FAST acronym (Face-Arm-Speech-Time): Face - sudden facial asymmetry, crooked smile; Arm - sudden weakness in one arm, inability to raise both arms equally; Speech - sudden difficulty speaking, slurred or unintelligible speech; Time - time is critical, seek care immediately. Other signs include: sudden vision loss in one or both eyes, sudden dizziness or loss of balance with other neurological symptoms, sudden difficulty walking, sudden and severe headache without apparent cause. Any focal neurological symptom of sudden onset, even if brief, requires urgent medical evaluation. Do not wait to see if symptoms improve - early treatment can prevent complete stroke.

---

Conclusion

Correct coding of transient ischemic attack using ICD-11 code 8B10 is fundamental for the appropriate management of this neurological emergency. Clear understanding of diagnostic criteria, especially the distinction between TIA and ischemic stroke based on neuroimaging findings, allows accurate coding and effective communication among health professionals. Recognition of the severity of TIA as a harbinger of complete stroke should motivate urgent investigation, aggressive preventive treatment, and careful follow-up to reduce the risk of subsequent cerebrovascular events.

External References

This article was prepared based on reliable scientific sources:

1. 🌍 WHO ICD-11 - Transient ischemic attack
2. 🔬 PubMed Research on Transient ischemic attack
3. 🌍 WHO Health Topics
4. 📊 Clinical Evidence: Transient ischemic attack
5. 📋 Ministry of Health - Brazil
6. 📊 Cochrane Systematic Reviews

References verified on 2026-02-03